Vivani Medical (VANI) Other financing activities (2014 - 2024)
Vivani Medical (VANI) posted Other financing activities of $3000.0 for Q1 2024, down 86.96% on a QoQ basis from $23000.0 in Q4 2023.
Powered by 
Analysis
Vivani Medical (VANI) Other financing activities (2014 - 2024) Analysis & Trends
Vivani Medical has reported Other financing activities for 6 years, with the latest figure at $3000.0 in Q1 2024.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $3000.0 in Q1 2024; TTM through Mar 2024 was $129000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $133000.0, changed N/A from the prior year.
- Other financing activities was $3000.0 for Q1 2024 at Vivani Medical, down from $23000.0 in the prior quarter.
- The five-year high for Other financing activities was $103000.0 in Q3 2023, with the low at $3000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.60 Bn | 621.84 Bn | 17.26 Bn |
| 2 | AbbVie | 447.11 Bn | 440.55 Bn | 12.70 Bn |
| 3 | Merck | 358.25 Bn | 351.11 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.57 Bn | 259.88 Bn | 11.24 Bn |
| 5 | Pfizer | 156.64 Bn | 144.94 Bn | 10.94 Bn |
| 6 | Sanofi | 52.20 Bn | 44.82 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.91 Bn | 42.91 Bn | - |
| 8 | Incyte | 24.64 Bn | 20.11 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn |
| 10 | Vivani Medical | 109.30 Mn | 89.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Dec 31, 2017 | 1.08 Mn |
| Mar 31, 2017 | 19.69 Mn |
| Jun 30, 2016 | 19.48 Mn |
| Mar 31, 2016 | 387.00 |
| Sep 30, 2015 | 196,723.00 |
| Jun 30, 2015 | 2.28 Mn |
| Mar 31, 2015 | 412.00 |
| Sep 30, 2014 | 69,464.00 |